Rational Development of Liquid Biopsy Analysis in Renal Cell Carcinoma

Rational Development of Liquid Biopsy Analysis in Renal Cell Carcinoma

Renal cell carcinoma (RCC) is known for its variable clinical behavior and outcome, including heterogeneity in developing relapse or metastasis. Recent data highlighted the potential of somatic mutations as promising biomarkers for risk stratification in RCC. Likewise, the analysis of circulating tu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kate I. Glennon, Mahafarin Maralani, Narges Abdian, Antoine Paccard, Laura Montermini, Alice Jisoo Nam, Madeleine Arseneault, Alfredo Staffa, Pouria Jandaghi, Brian Meehan, Fadi Brimo, Simon Tanguay, Janusz Rak, Yasser Riazalhosseini
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
renal cell carcinoma
liquid biopsy
NGS
cfDNA
ctDNA
extracellular vesicles
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/e16a1ef71eb64074ade75295117b9a5a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/e16a1ef71eb64074ade75295117b9a5a

Ejemplares similares